Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

101 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Crossed Wires: Protecting Medicines In Mexico

    Trademarks in Mexico are regulated under the Industrial Property Law (IPL) and its regulations.
    MexicoIntellectual Property
    Olivares
    Olivares
  • Article

    Modificación Al Acuerdo Por El Que Se Determinan Los Aditivos Y Coadyuvantes En Alimentos, Bebidas Y Suplementos Alimenticios, Su Uso Y Disposiciones Sanitarias

    México prohíbe el uso del colorante Eritrosina (Rojo 3 FD&C) en alimentos, bebidas y suplementos alimenticios a partir de mayo de 2026. Los fabricantes disponen de 24 meses para reformular productos que contengan este aditivo y agotar existencias, afectando categorías como helados, lácteos saborizados, bebidas no alcohólicas, productos de panificación y licores.
    MexicoFood, Drugs, Healthcare, Life Sciences
Greenberg Traurig
Greenberg Traurig
  • Article

    Recent Developments In Clinical Data Exclusivity

    Mexico, along with the United States and Canada, was one of the first countries to sign data protection provisions in a free trade agreement.
    MexicoFood, Drugs, Healthcare, Life Sciences
    Becerril Coca & Becerril
    Becerril Coca & Becerril
  • Article

    Regulatory Certainty For Biosimilars On The Horizon

    The frst time that biologics were ofcially recognised in the applicable legislation, the General Health Law, was in June 2009, with the inclusion of article 222-bis defning a ‘biologic/biotechnological product...
    MexicoFood, Drugs, Healthcare, Life Sciences
    Olivares
    Olivares
  • Article

    Publicación De Acciones De Simplificación Para Trámites Ante La Comisión Federal Para La Protección De Riesgos Sanitarios

    El pasado 27 de marzo de 2025, la Comisión Federal para la Protección contra Riesgos Sanitarios ("COFEPRIS") publicó en el Diario Oficial de la Federación (el "DOF") el Acuerdo por el que se establecen acciones de simplificación para trámites que se realizan ante la COFEPRIS.
    MexicoFood, Drugs, Healthcare, Life Sciences
    Greenberg Traurig
    Greenberg Traurig
  • Article

    Pharmaceutical IP And Competition Law In Mexico: Overview

    What are the legal conditions to obtain a patent and which legislation applies? Which products, substances and processes can be protected by patents and what types cannot be patent protected?
    MexicoIntellectual Property
    Olivares
    Olivares
  • Article

    Reformas En Materia De Publicidad De Alimentos Y Bebidas No Alcohólicas

    En lo que va del 2014 y con base en los derechos fundamentales a la salud y el interés superior de la niñez...
    MexicoFood, Drugs, Healthcare, Life Sciences
    Arochi & Linder
    Arochi & Linder
  • Article

    Actualización sobre la regulación de la Cannabis (marihuana) en México.

    A continuación algunas actualizaciones relevantes respecto de las disposiciones legales e iniciativas en el tema del uso de la Cannabis
    MexicoFood, Drugs, Healthcare, Life Sciences
    Greenberg Traurig
    Greenberg Traurig
  • Article

    Mexico's Patent Linkage System And Allopathic Medicines

    Over 20 years ago, derived from the innumerable and uncontainable violations of pharmaceutical patents and for publicity purposes of the patents that protect allopathic medicines...
    MexicoIntellectual Property
    Olivares
    Olivares
  • Article

    Impact In Mexico Of The U.S. 2026 Anti-Drug Strategy And The New Trade And Financial Compliance Paradigm Linked To National Security

    On May 4, 2026, the White House Office of National Drug Control Policy released the National Drug Control Strategy 20261 (“NDCS 2026”), a document that sets forth the U.S. government’s comprehensive strategy to, among other things, address the synthetic drug crisis (particularly fentanyl and methamphetamine) through a national security approach involving diplomatic, military, financial, and intelligence tools.
    MexicoFood, Drugs, Healthcare, Life Sciences
    Von Wobeser y Sierra, SC
    Von Wobeser y Sierra, SC
  • Article

    New Mexico Becomes Third U.S. State To Prohibit PFAS In Products

    In 2021, Maine became the first U.S. state to enact a law imposing reporting requirements and material restrictions on all products containing intentionally added perfluoroalkyl and polyfluoroalkyl substances (PFAS).
    MexicoEnvironment
    Beveridge & Diamond, P.C.
    Beveridge & Diamond, P.C.
  • Article

    Patent Law Reform In Mexico: A Strategic Turning Point, Particularly For The Pharma Sector

    In April 2026, Mexico implemented a significant reform of its intellectual property legislation, with the objective to modernise the system, accelerate procedures and provide greater legal certainty to innovators.
    MexicoIntellectual Property
    Novagraaf Netherlands BV
    Novagraaf Netherlands BV
  • Article

    Legal 500 Country Comparative Guides 2024

    Please briefly summarize your country's legislative framework for medicinal products (including biologicals), medical devices, food, and food supplements
    MexicoFood, Drugs, Healthcare, Life Sciences
    Olivares
    Olivares
  • Article

    Pharmaceutical Advertising 2017

    The Code of Ethics and Transparency of the Pharmaceutical Industry (Code of Ethics & Transparency).
    MexicoFood, Drugs, Healthcare, Life Sciences
    Olivares
    Olivares
  • Article

    ICLG To: Pharmaceutical Advertising 2016

    The primary legislation for the advertising of medicinal products is the General Health Law (Ley General de Salud) (HL), and its Regulations (Reglamento de la LGS en materia de Publicidad) (HLR).
    MexicoFood, Drugs, Healthcare, Life Sciences
    Olivares
    Olivares
  • Article

    Nueva Ley de los Impuestos Generales de Importación y de Exportación

    El 7 de junio de 2022 se publicó en el Diario Oficial de la Federación por la Secretaría de Economía (SE) el "DECRETO por el que se expide la Ley de los Impuestos Generales de Importación y de Exportación",...
    MexicoInternational Law
    Chevez
    Chevez
  • Article

    Medicinal Product Regulation And Product Liability In Mexico: Overview May 2017

    What are the main legislation and regulatory authorities for pharmaceuticals in your jurisdiction?
    MexicoFood, Drugs, Healthcare, Life Sciences
    Olivares
    Olivares
  • Article

    The Pharma Legal Handbook

    The Pharma Legal Handbook answers essential questions about the environment for pharmaceuticals in Mexico. It is a must have for any company operating in the country or looking to enter the market.
    MexicoFood, Drugs, Healthcare, Life Sciences
    Olivares
    Olivares
  • Article

    Life Sciences: Product Regulation And Liability In Mexico

    Are there any notable trends or recent legal developments in your jurisdiction's pharmaceutical industry? It is expected that the North American Free Trade Agreement will be soon reviewed, renegotiated or terminated.
    MexicoFood, Drugs, Healthcare, Life Sciences
    Olivares
    Olivares
  • Article

    Commercialisation Of Healthcare In Mexico: Overview

    This Q&A provides an overview of the regulatory framework for the commercialisation of medical products in Mexico.
    MexicoFood, Drugs, Healthcare, Life Sciences
    Olivares
    Olivares
  • Showing 81–100 of 101 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics